metricas
covid
Buscar en
Actas Urológicas Españolas (English Edition)
Toda la web
Inicio Actas Urológicas Españolas (English Edition) Risk models for patients with localized renal cell carcinoma
Journal Information
Vol. 41. Issue 9.
Pages 564-570 (November 2017)
Share
Share
Download PDF
More article options
Visits
6
Vol. 41. Issue 9.
Pages 564-570 (November 2017)
Original article
Risk models for patients with localized renal cell carcinoma
Modelos de riesgo en pacientes con carcinoma de células renales localizado
Visits
6
J.M. Velis
Corresponding author
jvelis@unav.es

Corresponding author.
, F.J. Ancizu, M. Hevia, I. Merino, A. García, P. Doménech, R. Algarra, A. Tienza, J.I. Pascual, J.E. Robles
Departamento de Urología, Clínica Universidad de Navarra, Pamplona, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Tables (7)
Table 1. Descriptive study of the series. Clinical-pathological characteristics.
Table 2. Influential variables in the DFS in the univariate study.
Table 3. Influential variables in the DFS in the multivariate study.
Table 4. DFS risk groups.
Table 5. Influencing variables in CSS in the univariate study.
Table 6. Variables influencing the CSS in the multivariate study.
Table 7. CSS risk groups.
Show moreShow less
Abstract
Introduction

We conducted a retrospective analysis of our series to assess the factors that influenced disease-free survival (DFS) and cancer-specific survival (CSS) for patients with localized renal cell carcinoma (RCC). We also created our own risk groups.

Material and methods

Between January 1990 and December 2012, 596 patients underwent surgery for localized RCC (clear cell, papillary or chromophobe). Using Cox regression models, we analyzed the clinical-pathological variables that influenced DFS and CSS and designed risk groups for DFS and CSS with the variables.

Results

The median follow-up for the series was 5.96 years. By the end of the study, 112 patients (18.8%) had a recurrence of the disease, with DFS rates of 82%, 77% and 72% at 5, 10 and 15 years, respectively. The independent factors that influenced DFS in the multivariate study were the following: A Furhman grade of 3–4, haematuria, lymphocytic or vascular invasion, the presence of tumor necrosis and a disease stage pT3-pT4. Furthermore, by the end of the study, 57 patients (9.6%) died due to renal cancer, with CSS rates of 92%, 86% and 83% at 5, 10 and 15 years, respectively. The independent factors that influenced CSS in the multivariate study were the following: A Furhman grade of 3–4, perinephric fat invasion and the presence of tumor necrosis.

Conclusions

Factors in addition to the disease stage pT3-pT4 in patients with localized RCC are important, such as the presence of haematuria and lymphocytic or vascular invasion for DFS. A Furhman grade of 3–4 and the presence of tumor necrosis are especially relevant for DFS and CSS.

Keywords:
Renal cell carcinoma
Prognostic factors
Renal risk model
Resumen
Introducción

Realizamos un análisis retrospectivo de nuestra serie para evaluar los factores influyentes en la supervivencia libre de enfermedad (SLE) y en la supervivencia cáncer-específica (SCE) en pacientes con carcinoma de células renales (CCR) localizado y realizamos unos grupos de riesgo propios.

Material y métodos

Entre enero de 1990 y diciembre de 2012 fueron operados 596 pacientes con CCR localizado (tanto de células claras como papilares o cromófobos). Se analizan las variables clinicopatológicas influyentes en la SLE y en la SCE mediante modelos de regresión de Cox y con ellas se diseñan grupos de riesgo de SLE y de SCE.

Resultados

La mediana de seguimiento de la serie es de 5,96 años. Al final del estudio 112 pacientes (18,8%) evidenciaron recidiva de la enfermedad, siendo la SLE del 82%, 77% y 72% a 5, 10 y 15 años respectivamente. Los factores de influencia independiente en la SLE en el estudio multivariado fueron: grado de Furhman III-IV, hematuria, afectación vascular linfática, la presencia de necrosis tumoral y el estadio patológico pT3-pT4. Por otro lado, al final del estudio 57 pacientes (9,6%) fallecieron a causa del cáncer renal, siendo la SCE del 92%, 86% y 83% a 5, 10 y 15 años respectivamente. Los factores de influencia independiente en la SCE en el estudio multivariado fueron: Grado de Furhman III-IV, afectación de la grasa perirrenal y la presencia de necrosis tumoral.

Conclusiones

Además del estadio patológico pT3-pT4 en pacientes con CCR localizado son importantes otros factores, como la presencia de hematuria y la afectación vascular linfática para la SLE; y especialmente relevantes el grado de Furhman III-IV y la presencia de necrosis tumoral tanto para la SLE como para la SCE.

Palabras clave:
Carcinoma células renales
Factores pronóstico
Modelo de riesgo renal

Article

These are the options to access the full texts of the publication Actas Urológicas Españolas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Actas Urológicas Españolas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos